Advertisement
Research Article

Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis

  • Dick Menzies mail,

    dick.menzies@mcgill.ca

    Affiliation: Respiratory and Epidemiology Clinical Research Unit, Montreal Chest Institute & Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Canada

    X
  • Andrea Benedetti,

    Affiliation: Respiratory and Epidemiology Clinical Research Unit, Montreal Chest Institute & Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Canada

    X
  • Anita Paydar,

    Affiliation: Respiratory and Epidemiology Clinical Research Unit, Montreal Chest Institute & Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Canada

    X
  • Ian Martin,

    Affiliation: Respiratory and Epidemiology Clinical Research Unit, Montreal Chest Institute & Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Canada

    X
  • Sarah Royce,

    Affiliation: University of California at San Francisco, San Francisco, California, United States of America

    X
  • Madhukar Pai,

    Affiliation: Respiratory and Epidemiology Clinical Research Unit, Montreal Chest Institute & Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Canada

    X
  • Andrew Vernon,

    Affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Christian Lienhardt,

    Affiliation: International Union against Tuberculosis and Lung Diseases, and Institut de Recherche pour le Développement, Paris, France

    X
  • William Burman

    Affiliation: Denver Public Health, Denver, Colorado, United States of America

    X
  • Published: September 15, 2009
  • DOI: 10.1371/journal.pmed.1000146

Reader Comments (0)

Post a new comment on this article